Mayne flags FY earnings jump despite weak quarter performance

MELBOURNE: ASX-listed pharma takeover target Mayne expects full year underlying earnings to range ... read more
MELBOURNE: ASX-listed pharma takeover target Mayne expects full year underlying earnings to range ... read more